Rufian S - Search Results

1

Impact of marginal quality donors on the outcome of liver transplantation.

Briceno J, Lopez-Cillero P, Rufian S, Diaz-Iglesias C, Solorzano G, Padillo J, De la Mata M, Pera C. Briceno J, et al. Among authors: rufian s. Transplant Proc. 1997 Feb-Mar;29(1-2):477-80. doi: 10.1016/s0041-1345(96)00213-8. Transplant Proc. 1997. PMID: 9123091 No abstract available.

2

Assignment of steatotic livers by the Mayo model for end-stage liver disease.

Briceño J, Padillo J, Rufián S, Solórzano G, Pera C. Briceño J, et al. Among authors: rufian s. Transpl Int. 2005 May;18(5):577-83. doi: 10.1111/j.1432-2277.2005.00091.x. Transpl Int. 2005. PMID: 15819807 Free article.

3

Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era.

Briceño J, Ciria R, de la Mata M, Rufián S, López-Cillero P. Briceño J, et al. Among authors: rufian s. Transplantation. 2010 Sep 15;90(5):530-9. doi: 10.1097/TP.0b013e3181e86b11. Transplantation. 2010. PMID: 20581766

4

Extended criteria donors in liver transplant candidates with hepatorenal syndrome.

Briceño J, Ciria R, de la Mata M, Montero JL, Rufián S, López-Cillero P. Briceño J, et al. Among authors: rufian s. Clin Transplant. 2011 May-Jun;25(3):E257-63. doi: 10.1111/j.1399-0012.2011.01402.x. Epub 2011 Feb 9. Clin Transplant. 2011. PMID: 21303415

5

Diminished anticoagulant and fibrinolytic activity following liver transplantation.

Velasco F, Villalba R, Fernandez M, de la Mata M, Roman J, Rubio V, Rufian S, Varo E, Pera C, Torres A. Velasco F, et al. Among authors: rufian s. Transplantation. 1992 Jun;53(6):1256-61. doi: 10.1097/00007890-199206000-00017. Transplantation. 1992. PMID: 1604481

6

Importance of surveillance mycobacterial cultures after liver transplantation.

Torre-Cisneros J, de la Mata M, Rufian S, Villanueva Marcos JL, Gutierrez Aroca J, Casal M, Miño G, Pera C. Torre-Cisneros J, et al. Among authors: rufian s. Transplantation. 1995 Nov 15;60(9):1054-5. Transplantation. 1995. PMID: 7491683

7

Adjuvant chemotherapy for prevention of recurrence of invasive hepatocellular carcinoma after orthotopic liver transplantation.

Bernal E, Montero JL, Delgado M, Fraga E, Costán G, Barrera P, López-Vallejos P, Solórzano G, Rufián S, Briceño J, Padillo J, López-Cillero P, Marchal T, Muntané J, de la Mata M. Bernal E, et al. Among authors: rufian s. Transplant Proc. 2006 Oct;38(8):2495-8. doi: 10.1016/j.transproceed.2006.08.053. Transplant Proc. 2006. PMID: 17097979

8

Contribution of marginal donors to liver transplantation for hepatitis C virus infection.

Briceño J, Ciria R, Pleguezuelo M, Naranjo A, Sánchez-Hidalgo J, Ruiz-Rabelo J, López-Cillero P, Luque A, de la Mata M, Rufián S. Briceño J, et al. Among authors: rufian s. Transplant Proc. 2007 Sep;39(7):2297-9. doi: 10.1016/j.transproceed.2007.07.069. Transplant Proc. 2007. PMID: 17889169

9

Model for end-stage liver disease can predict very early outcome after liver transplantation.

Briceño J, Sánchez-Hidalgo JM, Naranjo A, Ciria R, Pozo JC, Luque A, de la Mata M, Rufián S, López-Cillero P. Briceño J, et al. Among authors: rufian s. Transplant Proc. 2008 Nov;40(9):2952-4. doi: 10.1016/j.transproceed.2008.09.023. Transplant Proc. 2008. PMID: 19010157

10

Factors affecting survival and tumor recurrence in patients transplanted for hepatocellular carcinoma and coexistent hepatitis C virus.

Briceño J, Ruiz J, Ciria R, Naranjo A, Sánchez-Hidalgo J, Luque A, Rufián S, de la Mata M, López-Cillero P. Briceño J, et al. Among authors: rufian s. Transplant Proc. 2008 Nov;40(9):2990-3. doi: 10.1016/j.transproceed.2008.09.022. Transplant Proc. 2008. PMID: 19010170

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters